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Abstract
Objectives. Tenosynovitis (TS) is common in early arthritis. However, the value of US-defined TS in
predicting RA development is unclear. We assessed the predictive utility of US-defined TS alongside
US-defined synovitis and clinical and serological variables in a prospective cohort of early arthritis
patients.
Methods. One hundred and seven patients with clinically apparent synovitis of one or more joint and
symptom duration43 months underwent baseline clinical, laboratory and US assessment of 19 bilateral
joint sites and 16 bilateral tendon compartments. Diagnostic outcome was determined after 18 months,
applying the 2010 ACR/EULAR classification criteria for RA. The predictive values of US-defined TS for
persistent RA were compared with those of US-defined synovitis, clinical and serological variables.
Results. A total of 4066 US joint sites and 3424 US tendon compartments were included in the analysis.
Forty-six patients developed persistent RA, 17 patients developed non-RA persistent disease and 44
patients had resolving disease at follow-up. US-defined TS in at least one tendon compartment at base-
line was common in all groups (RA 85%, non-RA persistent disease 71% and resolving 70%). On multi-
variate analysis, US-defined digit flexor TS provided independent predictive data over and above the
presence of ACPA and US-defined joint synovitis.
Conclusion. US-defined digit flexor TS provided independent predictive data for persistent RA develop-
ment in patients with early arthritis. The predictive utility of this tendon site should be further assessed in a
larger cohort; investigators designing imaging-based predictive algorithms for RA development should
include this tendon component as a candidate variable.
Key words: tenosynovitis, ultrasound, rheumatoid arthritis, synovitis
Rheumatology key messages
. US-defined digit flexor tenosynovitis provides independent predictive data for RA development in early arthritis
patients.
. Clinicians should consider scanning digit flexor tendon sheaths alongside joints to enhance diagnostic confidence
for RA in early arthritis clinics.
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Introduction
Initiation of immunosuppressant therapy during the early
phases of RA alters the trajectory of disease progression
[1]. However, distinguishing individuals who are at risk of
progressing to RA from those whose disease will regress
amongst patients presenting with clinical arthritis within
12 weeks of symptom onset remains a challenge.
Many current predictive algorithms for RA progression
are based on clinical joint involvement, alongside clinical
and serological variables [2]. Musculoskeletal US is a non-
invasive and well-tolerated imaging technique and
has been shown to improve the predictive ability of such
algorithms [3, 4] due to the detection of subclinical
synovitis [5].
Tenosynovitis (TS) is a well-recognized clinical feature
of RA [69] and US is a reliable tool to assess TS in RA
patients [10, 11]. However, the ability of US-defined TS to
add data predictive of RA in patients with early clinically
apparent synovitis is currently unknown.
In this study, we described the frequency and distribu-
tion of US-defined TS at multiple sites in patients with
inflammatory arthritis of 43 months symptom duration.
We then determined whether US-defined TS provides pre-
dictive data over and above US-defined synovitis and
other clinical and serological variables.
Methods
Patients and clinical assessments
Patients were recruited from the Birmingham Early
Arthritis Clinic based in Rheumatology Departments at
Sandwell and West Birmingham Hospitals National
Health Service (NHS) Trust and University Hospitals
Birmingham NHS Foundation Trust, UK. All patients
were referred by their general practitioner to these two
secondary care centres, which provide rheumatology ser-
vice to a population of 1.3 million across Birmingham.
Consecutive DMARD-naı¨ve patients with clinically de-
tected synovitis of at least one joint and inflammatory joint
symptom duration (pain and/or stiffness and/or swelling)
of 43 months were included. Patients who had joint
symptoms attributed solely to degenerative joint disease
were excluded. This study was conducted with the ap-
proval of the Solihull Local Research Ethics Committee
and all patients gave written informed consent.
All consecutive patients who consented to this study
were included in the analysis except for those who
declined to continue follow-up before final diagnostic out-
come data were available. One hundred and seven pa-
tients were reviewed at 1, 2, 3, 6, 12 and 18 months,
and detailed clinical data were recorded at all visits,
including DMARD treatments. Final diagnostic outcomes
were determined at 18 month follow-up.
Patients were classified as having RA if they fulfilled
cumulative 2010 ACR/EULAR [12] criteria by the
18-month visit. Patients were classified as having resol-
ving disease at 18-month follow-up if they had no clinical
evidence of joint synovial swelling, were not taking
DMARDs and had not received steroid treatment (by any
route) in the previous 3 months. Non-RA patients were
classified according to established classification criteria,
which were PsA, SLE and AS [1315].
The following data were recorded at baseline: 68 tender
and 66 swollen clinical counts, age, sex, symptom dur-
ation, early morning stiffness duration, medication, ESR,
CRP, RF and ACPA status.
Sonographic assessment
Within 24 h of clinical assessment, one experienced sono-
grapher (A.F.) performed a blinded US assessment in a
temperature-controlled radiology suite. Systematic multi-
planar grey scale (GS) and power Doppler (PD) US exam-
inations of 19 bilateral joint sites and 16 bilateral tendon
compartments were performed based upon standard
EULAR reference scans [11] using a Siemens Acuson
Antares scanner (Siemens, Bracknell, UK) and multi-fre-
quency (513 MHz) linear array transducers. The joint and
tendon sites scanned are listed in supplementary Tables
S1 and S2, available at Rheumatology online, respectively.
For PD examinations, the pulse repetition frequency was
adjusted to provide maximal sensitivity at the lowest pos-
sible value for each joint, resulting in pulse repetition
frequencies of between 610 and 780. Examinations took
between 50 and 60 min depending on disease extent and
patient mobility.
US findings of GS synovitis and PD positivity were
defined according to consensus definitions [16, 17]. GS
synovitis and PD positivity in the MCP, PIP and MTP
joints were graded from 0 to 3 as reported previously [3].
Synovitis in other joints was graded as: 0, normal; 1, mild;
2, moderate; and 3, severe, as previously reported [3].
GS and PD TS changes were defined and graded ac-
cording to the OMERACT Ultrasound Task Force consen-
sus definitions [11]. GS TS was defined as abnormal
anechoic and/or hypoechoic (relative to tendon fibres)
tendon sheath widening that was related to tenosynovial
abnormal fluid and/or hypertrophy. PD TS was defined as
the presence of peritendinous Doppler signal within the
synovial sheath, seen in two perpendicular planes,
excluding normal feeding vessels.
Statistical analysis
Descriptive analysis
All data analyses were performed using IBM SPSS
Statistics for Windows (Version 20.0.; IBM Corp.,
Armonk, NY, USA). Baseline clinical variables between
groups were compared using KruskalWallis or Fisher’s
exact tests as appropriate. The proportions of patients
with US-defined synovitis and TS between the outcome
groups were compared using Fisher’s exact test. In de-
scriptive analyses, P40.017 (0.05/3) was considered
statistically significant after adjusting for the effect of mul-
tiple comparisons using the Bonferroni method.
Logistic regression and principal component analyses
The primary aim of this study was to identify the most
parsimonious combination of US, clinical and serological
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variables that, when applied to a cohort of patients with
early arthritis, identified patients progressing to RA by 18
months. All GS and PD US variables were binarized into
absent (grade = 0) or present (grade51). Univariate logis-
tic regression analysis was then performed to identify in-
dividual variables associated with the development of RA.
Secondly, principal component analysis (PCA) was used
to assess the degree of clustering amongst US joint and
tendon variables and then clinical variables. The resulting
selected variables were then used in a first multiple logis-
tic regression analysis.
A second logistic regression model was then developed
using systematic entry of US joint variable in order to con-
firm the independence of US-measured tendon and joint
variables in prediction of RA. All independent clinical and
serological variables were classified into categories
as listed in supplementary Table S3, available at
Rheumatology online.
Reliability analysis
The intra-observer reliability k values for joint and tendon
US scoring of GS and PD were excellent, with a k value of
0.83 for joint GS, 0.97 for joint PD, 0.96 for tendon GS and
0.95 for tendon PD. Further details and statistics for indi-
vidual joint sites and tendon compartments are listed in
supplementary Tables S4 and S5, available at
Rheumatology online.
Results
Patient characteristics
One hundred and seven patients were included in the ana-
lysis (baseline data are shown in Table 1). As sero-posi-
tivity for RF and/or ACPA is a strong predictor of RA,
results are presented for both the whole cohort and sero-
negative patients (defined as patients who were both RF-
and ACPA-negative).
Forty-six patients (43%) developed persistent RA
(referred to as RA hereafter), 17 patients (16%) developed
non-RA persistent inflammatory arthritis and the remain-
ing 44 (41%) had a resolving disease course, including 10
patients who fulfilled the 2010 ACR/EULAR criteria for RA
during the study period but whose disease had resolved
by 18 months of follow-up. Only two patients in this sub-
group had received DMARD therapy (which was subse-
quently withdrawn). Further details of these patients are
shown in supplementary Table S6, available at
Rheumatology online. Final diagnoses of patients within
the non-RA persistent inflammatory arthritis and resolving
groups are listed in supplementary Tables S6 and S7,
available at Rheumatology online. Of the 46 persistent
RA patients, 23 were seronegative.
Distribution of US-defined joint synovitis
A total of 4066 joints (i.e. 19 bilateral joints in 107 patients)
were included in the analysis. The distribution of US-
defined joint synovitis is presented in Fig. 1. Compared
with patients with resolving arthritis, RA patients were
more likely to have GS and PD changes at PIP 15,
MCP 15, wrist, elbow, MTP 3 and MTP 5 joints. In add-
ition, RA patients were more likely to have MTP 2 PD
changes, but not GS changes alone, compared with pa-
tients with resolving arthritis. The only US synovitis vari-
able discriminative of RA from all non-RA patients was
MCP 3 GS joint changes (Fig. 1A).
The distribution of US-defined joint synovitis for sero-
negative patients is presented in supplementary Fig. S1,
available at Rheumatology online. Compared with patients
with resolving arthritis, seronegative RA patients were
more likely to have GS changes at the PIP 2, MCP 1, 2,
4 and 5 joints and PD changes at the PIP 2, 3, MCP 1, 2, 3,
5, wrist and MTP 2 joints.
Distribution of US-defined TS
Some 3424 tendon compartments (i.e. 16 bilateral tendon
compartments in 107 patients) were included in the ana-
lysis. All patient groups had evidence of US-defined TS of
at least one anatomical site at baseline (RA 85%, non-RA
persistent disease 71% and resolving 70%). The distribu-
tion of US-defined TS by tendon region for all patients is
presented in Fig. 2. Compared with patients with resolving
arthritis, RA patients were more likely to have digit flexor
and wrist extensor US-defined TS, with both GS and PD
pathology. US-detected disease across the six wrist ex-
tensor compartments is presented in Fig. 2C and D.
Among the wrist extensor tendon compartments, US-
defined extensor carpi ulnaris (ECU) TS was more preva-
lent in RA patients compared with both patients with
resolving arthritis and non-RA patients. This was true for
both GS and PD.
The distribution of US-defined TS by tendon region for
seronegative patients is presented in supplementary Figs
S2 and S3, available at Rheumatology online. US-defined
digit flexor GS and PD TS were more prevalent in the RA
group compared with the resolving arthritis group (supple-
mentary Fig. S2, available at Rheumatology online).
Predictive value of clinical, serological and US
variables
Univariate analysis
Clinical and serological predictors of RA. Univariate logis-
tic regression analysis was performed with the clinical,
serological and US predictors as independent variables,
and RA vs non-RA outcome at 18 months as the depend-
ent variable.
The clinical, serological and US predictors of RA for all
patients on univariate analysis are shown in Table 2. Age
560 years, early morning stiffness of duration 560 min,
swollen joint count-66 and tender joint count-68 56 and
symptom duration 56 weeks were predictors of RA on
univariate analysis. The remaining clinical and serological
variables were not predictive of RA on univariate analysis
(supplementary Table S8, available at Rheumatology
online). In seronegative patients, only age 560 years,
early morning stiffness of duration 560 min and swollen
joint count-66 56 were predictors of seronegative RA
(supplementary Table S9, available at Rheumatology
online).
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US-defined joint synovitis predictors of RA. GS and PD
US synovitis of the MCP 15, PIP 15, wrist, MTP 3 and
MTP 5 joints were predictors of RA (Table 2). In addition,
MTP 2 PD joint synovitis, but not GS synovitis alone, was
a predictor of RA.
The GS joint US variables predictive of seronegative RA
were MCP 1, 3, 4, 5, PIP 1, 5 and MTP 5. The PD joint US
variables predictive of seronegative RA were MCP 1, 3, 5,
PIP 1, 2, 3, 4 and MTP 2. US-defined joint synovitis vari-
ables that were not predictive of RA and seronegative RA
are shown in supplementary Tables S10 and S11, avail-
able at Rheumatology online, respectively.
US-defined TS predictors of RA. US-defined digit flexor
and wrist ECU were predictive of RA. The predictive
abilities of GS and PD variables for each tendon compart-
ment were comparable (Table 2). The predictive values of
other tendon compartments are listed in supplementary
Table S12, available at Rheumatology online. For
seronegative patients, digit flexor and ECU remained as
predictors of seronegative RA. The predictive ability of GS
and PD for each tendon compartment was also
comparable (supplementary Table S13, available at
Rheumatology online).
PCA
In this step, statistically significant variables from the uni-
variate analysis were included in PCA analyses in order to
identify the key variables that would account for the ma-
jority of the explanatory variance observed. In particular,
we wished to test the hypothesis that US-measured joint
and tendon variables would cluster in separate compo-
nents, indicating non-correlation.
Two PCA analyses were performed, one for US and one
for clinical and serological variables. The number of com-
ponents extracted was based on eigenvalues with a cut-
off of one and the rotation method adopted was according
to the varimax criteria with Kaiser normalization.
The rotated factor loadings of the PCA for each clinical,
serological and US variable are shown in supplementary
Tables S14 and S15, available at Rheumatology online.
Three components were extracted from the clinical and
serological PCA, whilst nine components were extracted
from the joint and tendon US PCA (Table 3).
Multivariate logistic regression
Subsequently, a multiple logistic regression model was
developed using the variables identified by PCA. The
TABLE 1 Baseline characteristics for all patients and seronegative patients by diagnostic outcomes
Diagnostic group
Persistent
RA (RA)
Non-RA
persistent
(NRAP)
Resolving
(RES)
P-value*
RA vs NRAP
P-value* RA
vs RES
n (%) 46 (43) 17 (16) 44 (41)
Age, years 61 (4967) 39 (3264) 44 (3358) 0.019 0.003
Female, n (%) 24 (52) 11 (65) 25 (57) NA NA
Symptom duration, weeks 7 (59) 5 (48) 5 (37) 0.175 0.006
Morning stiffness, min 105 (60180) 60 (10180) 30 (060) 0.393 NS
NSAID use, n (%) 33 (72) 13 (76) 27 (61) NA NA
RF positivity, n (%) 22 (48) 2 (12) 3 (7) 0.010 <0.001
ACPA positivity, n (%) 20 (43) 1 (6) 3 (7) 0.006 <0.001
ESR, mm/h 24 (1239) 32 (1159) 18 (532) NA NA
CRP, mg/l 13 (534) 24 (939) 10 (127) NA NA
Swollen joint count of 66 7 (314) 2 (17) 2 (15) 0.002 <0.001
Tender joint count of 68 11 (415) 5 (212) 4 (17) 0.123 0.002
Presence of X-ray erosiona 1/46 (2.2) 1/16 (6.3) 1/39 (2.6) NA NA
Diagnostic group
Seronegative
persistent
RA (RA)
Seronegative
non-RA
persistent
(NRAP)
Seronegative
resolving
RES)
P-value
RA vs
NRAP
P-value
RA vs
RES
n (%) 23 (30) 14 (18) 39 (51)
Age, years 60 (4969) 39 (3272) 43 (3355) 0.84 0.023
Female, n (%) 11 (48) 9 (64) 22 (56) NA NA
Symptom duration, weeks 7 (59) 6 (48) 5 (37) 0.923 0.023
Morning stiffness, min 120 (60240) 60 (8180) 30 (560) 0.359 0.001
NSAID use, n (%) 15 (65) 10 (71) 25 (64) NA NA
ESR, mm/h 19 (747) 36 (1255) 18 (536) NA NA
CRP, mg/l 12 (026) 21 (536) 10 (129) NA NA
Swollen joint count of 66 7 (311) 2 (16) 2 (15) 0.005 0.001
Tender joint count of 68 12 (415) 5 (210) 5 (27) 0.093 0.027
All variables are shown as median (interquartile range) unless otherwise specified. aA total of 101 out of 107 patients had hand
and/or foot X-ray. *If the P-values for the comparison across the three groups is >0.05, the P-values of RA vs NRAP and RA
vs RES is not calculated (NA).
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variable with the highest loading factor from each compo-
nent was extracted and made available as an independent
variable in a forward step-wise multivariate logistic regres-
sion analysis, with RA outcome at 18 months entered as
the dependent variable. These variables are listed in sup-
plementary Table S16, available at Rheumatology online.
The logistic regression analysis identified PIP1 PD, digit
flexor GS and ACPA positivity as the variables which
formed the model for the prediction of RA, with the pro-
portion of RA vs non-RA identified as 75.7%
(supplementary Table S17, available at Rheumatology
online). In order to robustly confirm that US-measured
joint and tendon variables provided independent predict-
ive value, a further regression analysis was performed
(supplementary Table S17, available at Rheumatology
online). In this case, we systematically entered US joint
variables identified in the univariate analysis.
The optimal combination identified was MCP 3 PD, digit
flexor GS and ACPA positivity (Table 4), with the propor-
tion of RA vs non-RA patients correctly identified in our
FIG. 1 Distribution of joint US pathology in all patients
Each bar represents the proportion of patients with US-defined joint synovitis involvement defined by (A) Greyscale
synovial hypertrophy and (B) Power Doppler enhancement. P4 0.017 (i.e. 0.05/3) was considered statistically significant
as we adjusted for multiple comparisons using the Bonferroni method. VERA vs NRAP: zP < 0.001. VERA vs RES: *P <
0.017, **P < 0.001. VERA: very early RA; NRAP: non-RA persistent inflammatory arthritis; RES: resolving disease.
https://academic.oup.com/rheumatology 5
US TS and synovitis in RA prediction
Downloaded from https://academic.oup.com/rheumatology/advance-article-abstract/doi/10.1093/rheumatology/key025/4959183
by University of Birmingham user
on 07 June 2018
FIG. 2 Distribution of tendon US pathology in all patients
Each bar represents the proportion of patients US-defined tenosynovitis involvement according to (A) and (B) tendon
regions, (C) and (D) wrist extensor compartments. P < 0.017 (i.e. 0.05/3) was considered statistically significant as we
adjusted for multiple comparisons using the Bonferroni method. VERA vs NRAP: zP < 0.001. VERA vs RES *P < 0.017,
**P < 0.001. APL: abductor pollicis longus; EPB: extensor pollcis brevis; ECRL: extensor carpi radialis longus; ECRB:
extensor carpi radialis brevis; EPL: extensor pollicis longus; EDC: extensor digitorum communis; EIP: extensor indicis
propius; EDM: extensor digiti minimi; ECU: extensor carpi ulnaris; VERA: very early RA; NRAP: non-RA persistent in-
flammatory arthritis; RES: resolving disease.
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TABLE 2 Univariate analysis of clinical, serological and US variables at baseline for all patients in the prediction of RA
OR (95% CI) P-value
RA patients,
n (%) (n = 46)
Non-RA
patients,
n (%) (n = 61)
Clinical variables
Age 560 years 3.662 (1.595, 8.408) 0.002 24 (52) 14 (23)
Swollen joint count-66 56 joints 3.662 (1.595, 8.408) 0.002 24 (52) 14 (23)
Tender joint count-68 56 joints 2.456 (1.119, 5.394) 0.025 29 (63) 25 (41)
Early morning stiffness duration 560 min 3.972 (1.677, 9.408) 0.002 36 (78) 29 (48)
Symptom duration 56 weeks 2.878 (1.286, 6.445) 0.010 32 (70) 27 (44)
Serological variables
ACPA positivitya 10.962 (3.404, 35.298) 0.000 20 (43) 4 (7)
ACPA high-positivityb 9.161 (2.832, 29.635) 0.000 18 (39) 4 (7)
RF positivityc 10.267 (3.478, 30.304) 0.000 22 (48) 5 (8)
RF high-positivityd 17.293 (3.740, 79.951) 0.000 17 (37) 2 (3)
US variables
Joint US variablese
MCP 1 GS 5.349 (2.326, 12.299) 0.000 31 (67) 17 (28)
MCP 1 PD 6.966 (2.918, 16.627) 0.000 29 (63) 12 (20)
MCP 2 GS 4.243 (1.790, 10.055) 0.001 36 (78) 28 (46)
MCP 2 PD 4.194 (1.839, 9.567) 0.001 33 (72) 23 (38)
MCP 3 GS 6.338 (2.599, 15.455) 0.000 37 (80) 24 (39)
MCP 3 PD 7.333 (3.091, 17.398) 0.000 34 (74) 17 (28)
MCP 4 GS 4.770 (2.078, 10.949) 0.000 28 (61) 15 (25)
MCP 4 PD 3.818 (1.594, 9.144) 0.003 21 (46) 11 (18)
MCP 5 GS 3.997 (1.739, 9.186) 0.001 25 (54) 14(23)
MCP 5 PD 5.565 (2.167, 14.289) 0.000 21 (46) 8 (13)
PIP 1 GS 6.566 (2.200, 19.592) 0.001 17 (37) 5 (8)
PIP 1 PD 4.900 (1.615, 14.863) 0.005 14 (30) 5 (8)
PIP 2 GS 5.308 (2.248, 12.535) 0.000 26 (57) 12 (20)
PIP 2 PD 6.630 (2.712, 16.210) 0.000 26 (57) 10 (16)
PIP 3 GS 3.067 (1.350, 6.968) 0.007 23 (50) 15 (25)
PIP 3 PD 3.497 (1.457, 8.389) 0.005 20 (43) 11 (18)
PIP 4 GS 4.114 (1.523, 11.117) 0.005 16 (35) 7 (11)
PIP 4 PD 4.010 (1.402, 11.471) 0.010 14 (30) 6 (10)
PIP 5 GS 10.311 (2.783, 38.197) 0.000 16 (35) 3 (5)
PIP 5 PD 9.355 (2.514, 34.811) 0.001 15 (33) 3 (5)
Elbow GS 2.190 (0.986, 4.866) 0.054 22(48) 18 (30)
Elbow PD 2.394 (1.003, 5.714) 0.049 17 (37) 12 (20)
Wrist GS 4.963 (1.714, 14.369) 0.003 41 (89) 38 (62)
Wrist PD 6.042 (2.235, 16.331) 0.000 40 (87) 32 (52)
MTP 2 GS 1.967 (0.904, 4.280) 0.088 25 (54) 23 (38)
MTP 2 PD 5.029 (1.502, 16.844) 0.009 12 (26) 4 (7)
MTP 3 GS 3.077 (1.340, 7.065) 0.008 22 (48) 14 (23)
MTP 3 PD 8.194 (1.698, 39.536) 0.009 10 (22) 2 (3)
MTP 5 GS 7.600 (2.332, 24.770) 0.001 16(35) 4 (7)
MTP 5 PD 6.895 (2.105, 22.586) 0.001 15 (33) 4 (7)
Tendon US variable
Wrist ECU GS 6.071 (2.488, 14.818) 0.000 25 (54) 10 (16)
Wrist ECU PD 6.071 (2.488, 14.818) 0.000 25 (54) 10 (16)
Digit flexor GS 4.455 (1.892, 10.488) 0.001 24 (52) 12 (20)
Digit flexor PD 4.545 (1.901, 10.869) 0.001 23 (50) 11 (18)
Wrist extensor GS 2.963 (1.340, 6.551) 0.007 28 (61) 21 (34)
Wrist extensor PD 2.963 (1.340, 6.551) 0.007 28 (61) 21 (34)
Shoulder biceps GS 3.345 (1.472, 7.605) 0.004 24 (52) 15 (25)
Shoulder biceps PD 2.796 (1.094, 7.146 0.032 15 (33) 9 (15)
aACPA >7 IU/ml. bACPA >21 IU/ml. cRF >20 IU/ml. dRF >60 IU/ml. eGS grading 51; PD grading 51; US pathology was
present in at least unilateral joint. ECU: extensor carpi ulnaris tendon; GS: grey scale; OR: odds ratio; PD: power Doppler.
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cohort being 80.4%. Removing the digit flexor variable in
this regression model results in the proportion of RA vs
non-RA correctly identified falling from 80.4 to 73.8%.
Discussion
Previous studies have reported that US-defined joint
synovitis improves the prediction of RA above and
beyond clinical and serological variables in early arthritis
patients [3] and also improves the prediction of RA in
seronegative unclassified arthritis patients [18].
In this study, we showed that US-defined TS, specific-
ally digit flexor TS, provides additional predictive data
alongside US-defined joint synovitis and other clinical
and serological variables in a cohort of patients with
early arthritis.
These findings are consistent with studies of gadolin-
ium-enhanced MRI, in which digit flexor TS was a signifi-
cant predictor of early RA in a cohort of patients with
undifferentiated arthritis or clinically suspected RA with
no joint swelling [19]. In agreement with our data, the au-
thors concluded that MRI-defined digit flexor TS provided
additional predictive data for patients in their cohort even
in the presence of ACPA or RF. In addition, longitudinal
data from the Leiden Early Arthritis Clinic showed that
MRI-defined TS of the fifth ray flexor tendons was more
common in early arthritis patients who later developed RA
compared with those who did not [7].
Grassi et al. first described sonographic changes affect-
ing the hand flexor tendon in RA patients. The authors
reported that 90% (18/20) of RA patients had sonographic
changes at either digit flexor and/or extensor tendons [20].
Subsequent US studies described the distribution of
tendon involvement in the hands and/or wrists of RA pa-
tients [21, 22]. The present study is the first to describe the
distribution of US-defined TS of multiple tendon sites,
including the shoulder and ankle regions, in early arthritis.
In addition, this study includes the most extensive US
TABLE 3 Components from the clinical, serological and US PCA
PCA of clinical and serological variables
Components 1 2 3
Variables ACPA positivity
ACPA high-positivity
RF positivity
RF high-positivity
Swollen joint count-66 56
Tender joint count-68 56
Early morning stiffness
duration 560 min
Symptom duration
56 weeks
Age 560 years old
% of variance
explained
38.25 17.87 12.30
Cumulative % of variance explained = 68.41
PCA of US variables
Components 1 2 3 4 5 6 7 8 9
Variables MCP 1
MCP 2
MCP 3
MCP 4
PIP 2
PIP 3
PIP 4
PIP 5
PIP 1
PIP 4
Digit flexor MTP 2
MTP 3
ECU
Shoulder
tendon
MTP 5 Wrist joint MCP 5
% of variance
explained
38.01 8.54 7.21 5.84 5.29 4.26 3.97 3.69 3.12
Cumulative % of variance explained = 79.93
ECU: extensor carpi ulnaris tendon; PCA: principal component analyses.
TABLE 4 Logistic regression model
Variable OR 95% CI P-value Nagelkerke R2
% of patients correctly
identified (RA vs non-RA)
ACPA positivity 10.973 3.03139.730 0.000
0.439 80.4MCP 3 PD positivity 4.066 1.44411.444 0.008
Digit flexor tendon GS 3.078 1.0479.046 0.041
ACPA positivity 9.324 2.64832.832 0.001 0.402 73.8
MCP 3 PD positivity 6.451 2.52516.482 0.000
OR: odds ratio.
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assessment to date, including the MCP, PIP, wrist, MTP,
knee, ankle and elbow joints, and digit, wrist, shoulder
and ankle tendons.
One of the main challenges in US studies is identifying
the minimal joint, or tendon, subset that will provide the
maximal predictive ability for a given outcome [23]. We
performed a PCA of joint and tendon US variables to
identify redundant US variables within a given patient
group. Importantly, in this study we showed that
tendon US variables were not redundant with their cor-
responding regional joint US variables. For example,
digit flexor tendon US variables were not placed within
the same component as small joint synovitis variables of
MCP or PIP joints. Similarly, wrist ECU tendon involve-
ment did not share the same component as the wrist
joint US variable. These key findings, which are reported
for the first time in an early arthritis US study, suggest
that tendon US variables provide additional predictive
value alongside joint US variables in the context of
early arthritis.
One of the strengths of our study is that it was under-
taken prospectively in a real world setting. Consecutive
patients were recruited from well-established rheumatol-
ogy centres in the UK that had a wide catchment area.
Patients from our cohort also had very short symptom
duration, with median symptom duration of between
5 and 7 weeks. These findings suggest that US-detected
TS alongside US-detected joint synovitis is a reliable ima-
ging biomarker in the very early phase of arthritis, falling
within the proposed 12-week therapeutic window of op-
portunity of early arthritis [24].
Whilst several studies have assessed the tenosynovium
in patients with RA compared with healthy controls [6, 20],
an additional strength of our study is that we assessed the
predictive utility of TS assessment in a clinically meaning-
ful context of an unselected early arthritis cohort. The
comparator groups are patients with resolving and non-
RA disease—patients frequently seen in early arthritis
clinics and in relation to which management decisions
have to be made on the basis of prediction of future
outcomes.
The main limitation of our study relates to the relatively
small size of this initial cohort, necessitated by the exten-
sive imaging performed per patient. A larger sample size is
required in order to design weighted predictive algorithms
and identify specific domains such as individual flexor ten-
dons that provide the most useful predictive data in order
to reduce scanning time.
Previous imaging studies illustrated that gadolinium-
enhanced MRI-defined digit flexor TS is an independent
predictor of RA. Our findings demonstrate similar findings
for US, a more accessible point-of-care imaging tool. Our
data show that US-defined digit flexor TS provides inde-
pendent predictive value for RA development in early arth-
ritis patients. This finding should be further evaluated in a
larger study, and investigators testing imaging-based vari-
ables within predictive algorithms for RA development
should consider including this tendon component as a
candidate variable.
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